Form 4 Tracker
Natera, Inc.
NTRA

130 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 28, 2026Jul 28 8:40 PMMICHAEL BROPHY
Proposed Sale
1,178$258.03$304.0K—

View →

Jul 28, 2026Jul 28 8:08 PMJONATHAN SHEENA
Proposed Sale
188$258.03$48.5K—

View →

Jul 28, 2026Jul 28 8:08 PMDANIEL RABINOWITZ
Proposed Sale
988$258.03$254.9K—

View →

Jul 28, 2026Jul 28 8:08 PMSOLOMON MOSHKEVICH
Proposed Sale
1,185$258.03$305.8K—

View →

Jul 28, 2026Jul 28 8:08 PMJOH N FESKO
Proposed Sale
917$258.03$236.6K—

View →

Jul 28, 2026Jul 28 8:07 PMSTEVEN CHAPMAN
Proposed Sale
3,525$258.03$909.6K—

View →

Jul 28, 2026Jul 28 8:07 PMMICHAEL BROPHY
Proposed Sale
1,222$258.03$315.3K—

View →

Jul 27, 2026Jul 27 7:36 PMJONATHAN SHEENA
Proposed Sale
285$261.99$74.7K—

View →

Jul 27, 2026Jul 27 7:36 PMMATTHEW RABINOWITZ
Proposed Sale
1,697$261.99$444.6K—

View →

Jul 27, 2026Jul 27 7:36 PMDANIEL RABINOWITZ
Proposed Sale
873$261.99$228.7K—

View →

Jul 27, 2026Jul 27 7:36 PMSOLOMON MOSHKEVICH
Proposed Sale
998$261.99$261.5K—

View →

Jul 27, 2026Jul 27 7:36 PMJOHN FESKO
Proposed Sale
772$261.99$202.3K—

View →

Jul 27, 2026Jul 27 7:35 PMSTEVEN CHAPMAN
Proposed Sale
2,163$261.99$566.7K—

View →

Jul 27, 2026Jul 27 7:35 PMMICHAEL BROPHY
Proposed Sale
772$261.99$202.3K—

View →

Jul 15, 2026Jul 18 1:05 AMJonathan SheenaDirector, Other
Sale
1,500$273.88$410.8K18,032(I)

View →

Jul 15, 2026Jul 18 1:05 AMRowan E ChapmanDirector
Sale
135$274.82$37.1K4,663(D)

View →

Jul 13, 2026Jul 16 1:05 AMJonathan SheenaDirector, Other
Sale
3,150$265.68$836.9K246,202(D)

View →

Jul 15, 2026Jul 15 8:13 PMROWAN EMMA CHAPMAN
Proposed Sale
135$274.82$37.1K—

View →

Jul 15, 2026Jul 15 2:10 PMSheena Jonathan
Proposed Sale
1,500$275.22$412.8K—

View →

Jul 13, 2026Jul 13 3:05 PMSheena Jonathan
Proposed Sale
9,450$266.22$2.5M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 15, 2026Oct 17 1:35 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$10.410(D)

View →

Jun 5, 2026Jun 10 1:05 AMGail Boxer MarcusDirector
Option Exercise
11,000$22.8311,000(D)

View →

Apr 6, 2026Apr 9 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
58,292$9.590(D)

View →

Mar 31, 2026Apr 2 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
41,708$9.5958,292(D)

View →

Mar 16, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
50,000$9.59100,000(D)

View →

Mar 13, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59150,000(D)

View →

Mar 12, 2026Mar 17 1:05 AMMatthew RabinowitzDirector, EXECUTIVE CHAIRMAN
Option Exercise
75,000$9.59225,000(D)

View →

Mar 6, 2026Mar 11 1:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
5,598$19.680(D)

View →

Mar 2, 2026Mar 4 2:05 AMSolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICS
Option Exercise
5,125$9.590(D)

View →

Jan 20, 2026Jan 23 2:35 AMSteven Leonard ChapmanDirector, CEO AND PRESIDENT
Option Exercise
3,386—0(D)

View →

Jan 20, 2026Jan 23 2:35 AMMichael Burkes BrophyCHIEF FINANCIAL OFFICER
Option Exercise
1,522—0(D)

View →

Jan 20, 2026Jan 23 2:05 AMJonathan SheenaDirector, Other
Option Exercise
191—0(D)

View →

Jan 20, 2026Jan 23 2:05 AMDaniel RabinowitzSEC. AND CHIEF LEGAL OFFICER
Option Exercise
856—0(D)

View →